MIMEDX GROUP, INC. (MDXG) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001376339 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 29, 2026 | $64.4M | $-14.8M | $-0.10 | Filing |
| Mar 31, 2026 | Apr 29, 2026 | $59.0M | $-10.9M | $-0.07 | Filing |
| Dec 31, 2025 | Feb 25, 2026 | $118.1M | $15.2M | $0.10 | Filing |
| Sep 30, 2025 | Oct 29, 2025 | $113.7M | $16.7M | $0.11 | Filing |
| Jun 30, 2025 | Jul 30, 2025 | $98.6M | $9.6M | $0.06 | Filing |
| Mar 31, 2025 | Apr 30, 2025 | $88.2M | $7.0M | $0.05 | Filing |
| Dec 31, 2024 | Feb 26, 2025 | $92.9M | $7.4M | $0.05 | Filing |
| Sep 30, 2024 | Oct 30, 2024 | $84.1M | $8.1M | $0.05 | Filing |
What would MIMEDX GROUP, INC. have to report for its valuation to change?
At $4.43, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 56.8% a year, to $0.38. On that path the next quarter needs diluted EPS near $0.17, against $0.11 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 56.8% | 56.8% |
| EPS needed in final year | $0.38 | $0.38 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. MDXG goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.